UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

NanoFerrite Particle Based Radioimmunonanoparticles: Binding Affinity and In Vivo Pharmacokinetics

Bioconjugate chemistry, 2008-06, Vol.19 (6), p.1211-1218

2008

Volltextzugriff (PDF)

Radioimmunotherapy: recent results and future directions

Journal of clinical oncology, 1996-04, Vol.14 (4), p.1383-1400

1996

Volltextzugriff (PDF)

A review of human anti-globulin antibody (HAGA, HAMA, HACA, HAHA) responses to monoclonal antibodies. Not four letter words

The quarterly journal of nuclear medicine and molecular imaging, 2004-12, Vol.48 (4), p.251

2004

Volltextzugriff (PDF)

Molecular specific and cell selective cytotoxicity induced by a novel synthetic HLA-DR antibody mimic for lymphoma and leukemia

International journal of oncology, 2009-02, Vol.34 (2), p.511-516

2009

Volltextzugriff (PDF)

Practical Determination of Patient-Specific Marrow Dose Using Radioactivity Concentration in Blood and Body

The Journal of nuclear medicine (1978), 1999-12, Vol.40 (12), p.2102-2106

1999

Volltextzugriff (PDF)

Antibody Responses to Macrocycles in Lymphoma

The Journal of nuclear medicine (1978), 1996-03, Vol.37 (3), p.451-456

1996

Volltextzugriff (PDF)

Increased survival associated with radiolabeled lym‐1 therapy for non‐hodgkin's lymphoma and chronic lymphocytic leukemia

Cancer, 1997-12, Vol.80 (S12), p.2706-2711

1997

Volltextzugriff (PDF)

Radioimmunotherapy for breast cancer using indium- 111/yttrium-90 BrE-3 : Results of a phase I clinical trial

The Journal of nuclear medicine (1978), 1997-08, Vol.38 (8), p.1180-1185

1997

Volltextzugriff (PDF)

Yttrium-90-Labeled Monoclonal Antibody for Therapy: Labeling by a New Macrocyclic Bifunctional Chelating Agent

The Journal of nuclear medicine (1978), 1990-04, Vol.31 (4), p.473-479

1990

Volltextzugriff (PDF)

Development of anti-MUC1 di-scFvs for molecular targeting of epithelial cancers, such as breast and prostate cancers

The quarterly journal of nuclear medicine and molecular imaging, 2007-12, Vol.51 (4), p.304

2007

Volltextzugriff (PDF)

Prediction of Myelotoxicity Using Radiation Doses to Marrow from Body, Blood and Marrow Sources

The Journal of nuclear medicine (1978), 1997-09, Vol.38 (9), p.1374-1378

1997

Volltextzugriff (PDF)

Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma

Journal of clinical oncology, 1998-10, Vol.16 (10), p.3246-3256

1998

Volltextzugriff (PDF)

Pharmacokinetic Characterization in Xenografted Mice of a Series of First-Generation Mimics for HLA-DR Antibody, Lym-1, as Carrier Molecules to Image and Treat Lymphoma

The Journal of nuclear medicine (1978), 2007-08, Vol.48 (8), p.1338-1347

2007

Volltextzugriff (PDF)

Production of Soluble ScFvs with C-Terminal-Free Thiol for Site-Specific Conjugation or Stable Dimeric ScFvs on Demand

Bioconjugate chemistry, 2004-01, Vol.15 (1), p.16-26

2004

Volltextzugriff (PDF)

Treatment-related parameters predicting efficacy of Lym-1 radioimmunotherapy in patients with B-lymphocytic malignancies

Clinical cancer research, 1997-08, Vol.3 (8), p.1253-1260

1997

Volltextzugriff (PDF)

Anti-HLA-DR/anti-DOTA diabody construction in a modular gene design platform: Bispecific antibodies for pretargeted radioimmunotherapy

Cancer biotherapy & radiopharmaceuticals, 2001-12, Vol.16 (6), p.525-535

2001

Volltextzugriff (PDF)

Comparison of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA)-peptide-ChL6, a novel immunoconjugate with catabolizable linker, to 2-iminothiolane-2-[p-(bromoacetamido)benzyl]-DOTA-ChL6 in breast cancer xenografts

Clinical cancer research, 1998-10, Vol.4 (10), p.2483-2490

1998

Volltextzugriff (PDF)

Imaging for improved prediction of myelotoxicity after radioimmunotherapy

Cancer, 1997-12, Vol.80 (S12), p.2558-2566

1997

Volltextzugriff (PDF)

Prediction of Myelotoxicity Using Semi-Quantitative Marrow Image Scores

The Journal of nuclear medicine (1978), 1997-11, Vol.38 (11), p.1749-1754

1997

Volltextzugriff (PDF)

A revolution in the treatment of non-Hodgkin's lymphoma

Cancer biotherapy & radiopharmaceuticals, 1998-08, Vol.13 (4), p.213-223

1998

Volltextzugriff (PDF)

Prediction of Radiation Doses from Therapy Using Tracer Studies with Iodine-131-Labeled Antibodies

The Journal of nuclear medicine (1978), 1996-12, Vol.37 (12), p.1970-1975

1996

Volltextzugriff (PDF)

Neovascular targeting with cyclic RGD peptide (cRGDf-ACHA) to enhance delivery of radioimmunotherapy

Cancer biotherapy & radiopharmaceuticals, 2000-02, Vol.15 (1), p.71-79

2000

Volltextzugriff (PDF)

Trials and tribulations: Oncological antibody imaging comes to the fore

Seminars in nuclear medicine, 1997, Vol.27 (1), p.10-29

1997

Volltextzugriff (PDF)

Estimation of radiation absorbed doses to the red marrow in radioimmunotherapy

Clinical nuclear medicine, 1995-02, Vol.20 (2), p.117-125

1995

Volltextzugriff (PDF)

Lymphoma-selective antibody Lym-1 recognizes a discontinuous epitope on the light chain of HLA-DR10

Cancer Immunology, Immunotherapy, 1996-09, Vol.43 (1), p.26-30

1996

Volltextzugriff (PDF)

1 – 25 von 262

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(236)
Mit Volltextzugriff
(189)

Publikationsform

Artikel
(261)
Tagungsberichte
(1)

Sprache

Englisch
(262)

Erscheinungsjahr

n.n

Thema

Science & Technology
(182)
Life Sciences & Biomedicine
(179)
Female
(120)
Animals
(94)
Biological And Medical Sciences
(86)
Radiology, Nuclear Medicine & Medical Imaging
(85)
Medical Sciences
(83)
Oncology
(83)
Radioimmunotherapy
(83)
Male
(76)
Mice
(76)
Radionuclide Imaging
(67)
Antibodies, Monoclonal - Therapeutic Use
(61)
Middle Aged
(59)
Adult
(57)
Aged
(42)
Iodine Radioisotopes - Therapeutic Use
(39)
Pharmacology. Drug Treatments
(35)
Lymphoma, Non-Hodgkin - Radiotherapy
(33)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

NanoFerrite Particle Based Radioimmunonanoparticles: Binding Affinity and In Vivo Pharmacokinetics

Radioimmunotherapy: recent results and future directions

A review of human anti-globulin antibody (HAGA, HAMA, HACA, HAHA) responses to monoclonal antibodies. Not four letter words

Molecular specific and cell selective cytotoxicity induced by a novel synthetic HLA-DR antibody mimic for lymphoma and leukemia

Practical Determination of Patient-Specific Marrow Dose Using Radioactivity Concentration in Blood and Body

Antibody Responses to Macrocycles in Lymphoma

Increased survival associated with radiolabeled lym‐1 therapy for non‐hodgkin's lymphoma and chronic lymphocytic leukemia

Radioimmunotherapy for breast cancer using indium- 111/yttrium-90 BrE-3 : Results of a phase I clinical trial

Yttrium-90-Labeled Monoclonal Antibody for Therapy: Labeling by a New Macrocyclic Bifunctional Chelating Agent

Development of anti-MUC1 di-scFvs for molecular targeting of epithelial cancers, such as breast and prostate cancers

Prediction of Myelotoxicity Using Radiation Doses to Marrow from Body, Blood and Marrow Sources

Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma

Pharmacokinetic Characterization in Xenografted Mice of a Series of First-Generation Mimics for HLA-DR Antibody, Lym-1, as Carrier Molecules to Image and Treat Lymphoma

Production of Soluble ScFvs with C-Terminal-Free Thiol for Site-Specific Conjugation or Stable Dimeric ScFvs on Demand

Treatment-related parameters predicting efficacy of Lym-1 radioimmunotherapy in patients with B-lymphocytic malignancies

Anti-HLA-DR/anti-DOTA diabody construction in a modular gene design platform: Bispecific antibodies for pretargeted radioimmunotherapy

Comparison of 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA)-peptide-ChL6, a novel immunoconjugate with catabolizable linker, to 2-iminothiolane-2-[p-(bromoacetamido)benzyl]-DOTA-ChL6 in breast cancer xenografts

Imaging for improved prediction of myelotoxicity after radioimmunotherapy

Prediction of Myelotoxicity Using Semi-Quantitative Marrow Image Scores

A revolution in the treatment of non-Hodgkin's lymphoma

Prediction of Radiation Doses from Therapy Using Tracer Studies with Iodine-131-Labeled Antibodies

Neovascular targeting with cyclic RGD peptide (cRGDf-ACHA) to enhance delivery of radioimmunotherapy

Trials and tribulations: Oncological antibody imaging comes to the fore

Estimation of radiation absorbed doses to the red marrow in radioimmunotherapy

Lymphoma-selective antibody Lym-1 recognizes a discontinuous epitope on the light chain of HLA-DR10

Aktive Filter

Suchergebnisse filtern